

Fundamental dimension Equity attribute | AORTPeer $23.30▼-2.80% Cap $1.14BP/E -390.9x QuantScore52/100 | ADUSLeader $121.81▼-0.70% Cap $2.27BP/E 21.4x QuantScore65/100 | ARDTPeer $12.27▼-0.73% Cap $1.73BP/E 22.3x QuantScore56/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
63/100 |
84/100 |
84/100 |
Valuation Multiples, PEG & DCF upside | 23/100 | 83/100 | 95/100 |
Health Piotroski, Altman Z, leverage & liquidity | 35/100 | 78/100 | 39/100 |
Growth Revenue / earnings growth & margins | 61/100 | 45/100 | 15/100 |
Sentiment Analyst ratings, targets & revisions | 80/100 | 35/100 | 46/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -390.9x | 21.4x | 22.3x |
Forward P/E (next FY) | -86.3x | 17.3x | 12.8x |
EV / EBITDA (TTM) | 28.7x | 13.6x | 8.1x |
Price / Sales | 2.4x | 1.5x | 0.3x |
Price / Free Cash Flow | -104.2x | 14.9x | 5.8x |
PEG ratio | 1.77 | 0.92 | -0.32 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 6 / 9 | 5 / 9 |
Altman Z-Score | 1.81 (Grey) | 6.38 (Safe) | 2.05 (Grey) |
Total debt / equity | 0.92 | 0.09 | 1.68 |
Quick ratio | 2.5x | 1.7x | 2.0x |
Interest coverage | 0.8x | 14.9x | 9.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +13.6% | +23.2% | +6.0% |
Net income growth YoY | +173.1% | +30.3% | -35.4% |
Gross margin (TTM) | 62.8% | 32.4% | 30.0% |
Operating margin (FY) | 6.1% | 9.7% | 5.1% |
FCF margin (FY) | -0.2% | 7.3% | 4.1% |
5. Trailing price performancePrice change over period |
1M return | +1.2% | +6.8% | +17.1% |
3M return | -7.8% | +6.3% | +15.3% |
6M return | -38.3% | +27.3% | +26.6% |
Year to date | -48.9% | +13.4% | +39.0% |
1Y return | -46.3% | +0.1% | -19.3% |
3Y return | +76.5% | +48.1% | -23.6% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.5929 -102.5% premium | $128.82 +5.8% upside | $37.33 +204.2% upside |
Wall Street consensus target | $38.67 +66.0% · range $31.00–$45.00 | $122.33 +0.4% · range $96.00–$137.00 | $12.67 +3.3% · range $11.00–$14.00 |
Consensus stance | 83% Buy17% Hold-0% Sell | 81% Buy13% Hold6% Sell | 67% Buy25% Hold8% Sell |